Last $32.87 USD
Change Today +0.02 / 0.06%
Volume 2.6M
ZTS On Other Exchanges
Symbol
Exchange
Berlin
As of 8:04 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

zoetis inc (ZTS) Key Developments

Zoetis Mulls Acquisitions

Zoetis Inc. (NYSE:ZTS) is looking for acquisitions. Juan Ramon Alaix, Chief Executive Officer of Zoetis Inc. said, "We think that we can generate external growth with acquisitions. Zoetis will generate the cash to consider this opportunities. It is something that is also part of our strategic initiative."

Zoetis Inc. Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-10-2014 01:20 PM

Zoetis Inc. Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-10-2014 01:20 PM. Venue: Terranea Resort in Rancho Palos Verdes, 100 Terranea Way, Los Angeles, California, United States. Speakers: Juan Ramón Alaix, Chief Executive Officer and Director.

Zoetis Inc. Presents at William Blair & Company's 34th Annual Growth Stock Conference, Jun-12-2014 08:40 AM

Zoetis Inc. Presents at William Blair & Company's 34th Annual Growth Stock Conference, Jun-12-2014 08:40 AM. Venue: Four Seasons Hotel, 120 East Delaware Place, Chicago, Illinois, United States. Speakers: Juan Ramón Alaix, Chief Executive Officer and Director.

Zoetis Inc. Presents at BMO Capital Markets 2014 Farm to Market Conference, May-22-2014 01:25 PM

Zoetis Inc. Presents at BMO Capital Markets 2014 Farm to Market Conference, May-22-2014 01:25 PM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Juan Ramón Alaix, Chief Executive Officer and Director.

Zoetis Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Year 2014

Zoetis Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported revenue of $1,097 million against $1,090 million a year ago. Income before provision for taxes on income was $227 million against $192 million a year ago. Net income attributable to the company was $155 million against $140 million a year ago. Earnings per share basic and diluted were $0.31 against $0.28 a year ago. Adjusted net income attributable to the company was $191 million against $179 million a year ago. Earnings per share basic and diluted were $0.38 against $0.36 a year ago. For the year 2014, the company expects revenue of $4,650 million to $4,750 million. The company expects adjusted interest expense and other (income)/deductions to be approximately $105 million. Effective tax rate on adjusted income is expected to be approximately 29%. Adjusted diluted EPS is expected to be $1.48 to $1.54. Reported diluted EPS is expected to be $1.15 to $1.21. The company expects adjusted net income of $740 million to $770 million. The company expects reported net income attributable to the company of $580 million to $610 million. The company continues to expect an effective tax rate for the year of approximately 29%. Diluted EPS for full year of 2014 remains between $1.15 and $1.21 per share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZTS:US $32.87 USD +0.02

ZTS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €99.75 EUR +0.55
ImmuCell Corp $4.60 USD +0.08
Merck & Co Inc $58.43 USD +0.43
Valneva SE €4.88 EUR +0.01
Virbac SA €156.95 EUR -0.30
View Industry Companies
 

Industry Analysis

ZTS

Industry Average

Valuation ZTS Industry Range
Price/Earnings 31.7x
Price/Sales 3.6x
Price/Book 15.3x
Price/Cash Flow 28.4x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZOETIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.